AUTHORS
Lu Zhou, MBBS, Wen Zhu, MD, PhD2, Mei Yu, PhD3, Yuhong Chen, PhD4, Gowthami Arepally, MD5, Anand Pabmanabhan, MBBS, PhD6, Demin Wang, PhD7, Renren Wen, PhD8
AFFILIATIONS
1 Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
2 Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
3 Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
4 Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
5 Duke University Medical Center, Durham, North Carolina, United States
6 Mayo Clinic, Phoenix, Arizona, United States
7 Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
8 Medical College of Wisconsin, Milwaukee, Wisconsin, United States, Versiti Blood Research Institute, Milwaukee, Wisconsin, United States
ABSTRACT
Introduction
Heparin-induced thrombocytopenia (HIT) is a serious immune-mediated complication of heparin therapy caused by platelet-activating IgG antibodies against platelet factor 4/heparin (PF4/H) complexes. These antibodies develop rapidly, resembling a memory response even in clinically heparin-naïve patients, yet decline quickly and recur with similar kinetics upon re-exposure, suggesting a naïve-like response with limited capacity to long-term immunological memory. The cellular basis for these unusual immune characteristics remains poorly understood. B-cell responses generally arise through either germinal center (GC) or extrafollicular (EF) pathways. Compared with GC responses, EF responses rapidly generate class-switched and unswitched antibodies with limited somatic hypermutation, affinity maturation, and long-term memory. Inflammatory EF responses are commonly driven by the IL-12–IFN-γ axis and are characterized by expansion of activated naïve B cells (aNBCs) and atypical memory B cells (AtyMBCs). The distinctive serological features of HIT led us to hypothesize that the platelet-activating anti-PF4/H antibody response is predominantly an EF B-cell response.
Methods
Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq) combined with single-cell V(D)J sequencing (scV(D)J-seq) was performed on peripheral blood B cells isolated from 5 HIT patients, 5 non-HIT (NHIT) patients with PF4/H antibodies but without clinical HIT, and 4 healthy donors (HD). Integrated CITE-seq and B-cell receptor repertoire analyses were performed to characterize B-cell composition, signaling pathways, somatic hypermutation, clonal architecture, and differentiation trajectories. Recombinant monoclonal antibodies derived from selected clones were synthesized and functionally validated in binding assays and platelet activation assays.
Results
Both HIT and NHIT exhibited enrichment of aNBCs and AtyMBCs, with increased IFN-γ signaling. HIT uniquely showed greater expansion of plasmablasts (PBs) and stronger inflammatory and metabolic programs, with preferential NF-κB activation in AtyMBCs, consistent with a more pronounced inflammatory EF B-cell response.
scV(D)J profiling of total B cells revealed significantly reduced somatic hypermutation frequencies across the complementarity-determining regions (CDRs) and framework regions of both heavy and light chains in HIT and NHIT compared with HD, with the greatest reduction observed in the heavy-chain (HC) repertoire of HIT, particularly among PBs. In addition, HIT was further characterized by longer HC CDR3 (HCDR3) sequences enriched in basic amino acids and tyrosine residues, consistent with structural features previously identified in cloned platelet-activating antibodies (Zhu et al., Blood, 2023; Zhou et al., Blood, 2026). These HCDR3 features have also been associated with polyreactive and autoreactive antibodies generated during inflammatory EF B-cell responses.
scV(D)J profiling of expanded B-cell clones further identified selective expansion of IGHJ6-expressing clones within AtyMBCs and PBs in HIT, but not in NHIT or HD. The expanded clones exhibited lower somatic hypermutation frequencies and increased IFN-γ signaling than those in NHIT. Notably, a significantly greater proportion of expanded B-cell clones in HIT contained the HCDR3 RKH or Y5 motifs. Both preferential IGHJ6 usage and the HCDR3 RKH and Y5 motifs have previously been identified as structural features of cloned platelet-activating antibodies in HIT (Zhu et al., Blood, 2023; Zhou et al., Blood, 2026).
Pseudotime trajectory analysis identified two differentiation pathways leading to PBs in HIT: naïve→aNBCs→PBs and naïve→unswitched memory B cells→AtyMBCs→PBs. Consistent with these trajectories, both aNBCs, AtyMBCs and PBs were expanded in HIT, supporting an EF response.
Importantly, a significant proportion of recombinant monoclonal antibodies generated from expanded clones or RKH- or Y5 motif-bearing clones were PF4/H-reactive and exhibited poly- and autoreactivity in ELISA. A large proportion of these antibodies also induced platelet activation in a P-selectin expression assay.
Conclusion
Our findings support a model in which an inflammatory EF B-cell program drives the differentiation of naïve B cells into platelet-activating antibody-secreting PBs, providing a mechanistic explanation for the distinctive immune response in HIT and identifying potential targets for immune-directed therapy.
DISCLOSURES
Lu Zhou, MBBS: No relevant conflicts of interest to declare.